Status:
RECRUITING
VItamin D in pregnanCy for prevenTion Of eaRlY Childhood Asthma
Lead Sponsor:
Professor Klaus Bønnelykke
Conditions:
Asthma
Respiratory Tract Infections
Eligibility:
FEMALE
18-45 years
Phase:
PHASE3
Brief Summary
The overall aim of the study is to develop a nutritional preventive vitamin D supplementation strategy in pregnancy for early childhood asthma/persistent wheeze during the first three years of life as...
Detailed Description
Randomization of 2000 pregnant women to vitamin D of high-dose (3200 IU/day) vitamin D vs placebo on top of the recommended 400 IU/day. Supplementation begins in gestational week 24 (22-26) until 1 we...
Eligibility Criteria
Inclusion
- Pregnant Danish women before week 26 with blood levels of EPA+DHA above 4.7% of total fatty acids
- No current vitamin D intake above the recommended 400 IU/day
- No endocrine-, heart-, kidney- or auto-immune disorders
- No disorders requiring treatment with blood thinning medication
Exclusion
Key Trial Info
Start Date :
December 20 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2033
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT06570889
Start Date
December 20 2024
End Date
March 1 2033
Last Update
September 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Copenhagen University Hospital of Copenhagen
Gentofte Municipality, Denmark, DK-2820